molnupiravir
molnupiravir: 3 clinical trials tracked.
molnupiravir evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
What is verified about molnupiravir, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Clinical Trial Registry Records (3)
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression
Primary endpoint: Percentage of Participants Who Experienced One or More of Following Through Day 29: All-cause Hospitalization, All-cause Mortality, or Covid-19-related Medically-attended Visit (MAV)
Finding Treatments for COVID-19: A Phase 2 Multi-centre Adaptive Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
Primary endpoint: Rate of viral clearance for interventions relative to the no study arm (This is a superiority comparison)
Randomised Evaluation of COVID-19 Therapy
Primary endpoint: Community-acquired pneumonia: All-cause mortality (with subsidiary analyses of cause of death and of death at various timepoints following discharge)